Principal Securities’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $615K | Sell |
7,413
-4,762
| -39% | -$395K | 0.01% | 775 |
|
|
2025
Q1 | $1.1M | Buy |
12,175
+69
| +0.6% | +$6.21K | 0.02% | 522 |
|
|
2024
Q4 | $1.09M | Buy |
12,106
+3,325
| +38% | +$299K | 0.02% | 522 |
|
|
2024
Q3 | $868K | Buy |
8,781
+454
| +5% | +$44.9K | 0.02% | 573 |
|
|
2024
Q2 | $772K | Buy |
8,327
+2,418
| +41% | +$224K | 0.02% | 554 |
|
|
2024
Q1 | $561K | Sell |
5,909
-483
| -8% | -$45.8K | 0.02% | 621 |
|
|
2023
Q4 | $571K | Buy |
+6,392
| New | +$571K | 0.02% | 552 |
|